EMV 3.47% $2.09 emvision medical devices ltd

Ann: Trial data confirms early ischaemia detection capabilities, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,264 Posts.
    lightbulb Created with Sketch. 388
    Once again, performance in line with expectations. This is exciting news. One particular comment stood out for me:

    “The AI model demonstrates an encouraging ability to identify patterns and features in the signals across complex ischaemic patient data sets, including cases of very early onset hyperacute ischaemic stroke where there are no or minimal non-diagnostic radiological findings on traditional CT (NCCT).”

    My understanding of this is the EMU diagnosed early onset ischemia that NCCT couldn’t. This bodes very well going forward, especially from a Gen2 perspective.
 
watchlist Created with Sketch. Add EMV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.